GOSS compared with SPCE: revenue, margins and what each company keeps, and the suppliers and customers both name

GOSSGossamer Bio, Inc.

Mkt capRevenueRevenue

SPCEVirgin Galactic Holdings, Inc

Mkt capRevenueRevenue

Compare

GOSSGossamer Bio, Inc.

SPCEVirgin Galactic Holdings, Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GOSS 3

—Chiesiunlistedcustomer

—Pulmokineunlistedsupplier

—Respira Therapeuticsunlistedsupplier

Shared 0

No shared counterparties.

Only SPCE 14

—Pratt and Whitney Canadaunlistedsupplier

—Virgin Enterprises Limited (VEL)unlistedsupplier

—New Mexico Spaceport Authorityunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Spaceport Americaunlistedsupplier

10 more · SPCE chain ›

GOSSGossamer Bio, Inc.

9.03▼−4.47%· post 9.03· delayed

Mkt cap$57.7MRevenue$9MQ2 FY26Revenue$48MFY25

SPCEVirgin Galactic Holdings, Inc

2.51▲+1.42%· post 2.50· delayed

After hoursNov 3 '26delayed

Mkt cap$374.4MRevenue$9MQ2 FY26Revenue$36MFY24

Compare

After hoursNov 3 '26delayed

GOSSGossamer Bio, Inc.

SPCEVirgin Galactic Holdings, Inc

9.03▼−4.47%post 9.03delayed

Price

2.51▲+1.42%post 2.50delayed

$57.7M

Mkt cap

$374.4M

Q2 FY26$9M

Revenue

$9MQ2 FY26

FY25$48M

Revenue

$36MFY24

GOSS9.03▼−4.47%vsSPCE2.51▲+1.42%After hoursNov 3 '26delayed